Establishment method of high performance liquid chromatography fingerprint of bulbus fritillariae cirrhosae cough relieving mixture

The high-performance liquid chromatography fingerprinting method was used to solve the problem of incomplete quality control of Chuanbei Zhike Mixture. A fingerprint spectrum with high compound separation and good repeatability was established, realizing comprehensive monitoring and stable control of the quality of Chuanbei Zhike Mixture.

CN118914436AActive Publication Date: 2024-11-08山东宏济堂制药集团股份有限公司
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411181643.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-27
Publication Date
2024-11-08
Estimated Expiration
2044-08-27

AI Technical Summary

Technical Problem

In the existing technology, the quality control method of Chuanbei Zhike Mixture is relatively simple and cannot fully reflect its intrinsic quality, resulting in low quality standards and an inability to effectively guarantee the consistency of drug quality.

Method used

A high-performance liquid chromatography (HPLC) fingerprinting method was used to establish the fingerprint of Chuanbei Zhike Mixture by preparing test sample, reference standard and reference medicinal material solutions, combined with a specific mobile phase and gradient elution program. Rosmarinic acid and other components were used as references to ensure high compound separation and good reproducibility.

Benefits of technology

It enables comprehensive monitoring of the quality of Chuanbei Zhike Mixture, provides a simple, stable and precise quality control method, ensures the consistency of the drug's intrinsic quality, and has good reproducibility.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118914436A_ABST
    Figure CN118914436A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of pharmaceutical analysis, and particularly relates to a method for establishing a high performance liquid chromatography fingerprint of a bulbus fritillariae cirrhosae cough relieving mixture. The establishment method of the high performance liquid chromatography fingerprint of the bulbus fritillariae cirrhosae cough-relieving mixture comprises the following steps: (1) preparing a test solution; (2) preparing a reference substance solution; (3) preparing a reference medicinal material solution; (4) high performance liquid chromatography determination; respectively taking a proper amount of the test solution, the reference substance solution and the reference medicinal material solution by adopting optimized chromatographic conditions, injecting the solutions into a high performance liquid chromatograph, and recording chromatograms; and analyzing the high performance liquid chromatograms of the multiple batches of test sample solutions to obtain a control fingerprint spectrum of the bulbus fritillariae cirrhosae cough relieving mixture, and calculating the relative retention time of each common peak. The method has the advantages of high compound separation degree and good repeatability, the fingerprint spectrum provided by the method is used for determining the characteristic compound in the bulbus fritilariae cough relieving mixture, and the quality of the bulbus fritilariae cough relieving mixture can be effectively represented and comprehensively monitored.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of drug analysis, and specifically relates to a method for establishing a high performance liquid chromatography fingerprint of Chuanbei Zhisou mixture. Background Art

[0002] Chuanbei cough-relieving mixture is included in the third volume of the Ministry of Health's drug standard Chinese medicine formula preparation: WS3-B-0489-91. It is composed of 8 Chinese medicinal materials, including 150g of Aster tataricus, 150g of Perilla leaf, 10g of Fritillaria cirrhosa, 150g of Platycodon grandiflorum, 20g of Pinellia ternata, 50g of Licorice, 40ml of Apricot kernel water, and 2ml of mint water. It has the effects of dispelling exterior pathogens, promoting lung function, relieving cough and reducing phlegm, and is often used for symptoms of exogenous cough.

[0003] Chuanbei Antisough Mixture has many medicinal flavors and complex chemical components, and its quality control research is relatively small. The Chuanbei Antisough Mixture recorded in the standard is only subject to quality control based on physical and chemical identification of alkaloids and saponins, pH value, relative density and inspection under the mixture. The quality standard is low and cannot fully reflect the intrinsic quality of Chuanbei Antisough Mixture, and cannot guarantee comprehensive control of the quality of Chuanbei Antisough Mixture. Summary of the invention

[0004] In order to solve the above problems, a method for establishing a high performance liquid chromatography fingerprint of Chuanbei Antisough Mixture is provided. The method has the advantages of high compound separation and good repeatability. The fingerprint provided by the method is used to determine the characteristic compounds in Chuanbei Antisough Mixture, which can effectively characterize and comprehensively monitor the quality of Chuanbei Antisough Mixture.

[0005] The present invention provides a method for establishing a high performance liquid chromatography fingerprint of Chuanbei Zhisou mixture, comprising the following steps:

[0006] (1) Preparation of test solution:

[0007] Place a certain volume of Chuanbei Zhisou mixture in a container, add an appropriate amount of methanol to dilute and shake well, filter, and take the filtrate as the test solution;

[0008] (2) Preparation of reference solution:

[0009] Take a certain weight of rosmarinic acid, ammonium glycyrrhizinate, p-hydroxybenzoic acid and caffeic acid, place them in volumetric flasks respectively, add appropriate amount of methanol and perform ultrasonic treatment, cool, shake well, and filter to obtain a reference solution; wherein rosmarinic acid is used as a reference;

[0010] (3) Preparation of control medicinal material solution:

[0011] Take a certain weight of Aster tataricus, Perilla leaf, Platycodon grandiflorum, Licorice root, Pinellia ternata and Fritillaria cirrhosa respectively, prepare single medicinal material solutions according to the process specifications, take a certain volume of the single medicinal material solution and put it in a container, add an appropriate amount of methanol and shake well, filter, and take the filtrate as the control medicinal material solution;

[0012] (4) High performance liquid chromatography determination:

[0013] Taking appropriate amounts of the test solution, the reference solution and the reference medicinal material solution respectively, injecting them into a high performance liquid chromatograph, and recording the chromatograms; analyzing the high performance liquid chromatograms of multiple batches of the test solution to obtain the reference fingerprint of Chuanbei Zhisou Mixture, and calculating the relative retention time of each common peak;

[0014] The chromatographic conditions of the high performance liquid chromatograph are:

[0015] The mobile phase includes mobile phase A and mobile phase B, mobile phase A is acetonitrile, and mobile phase B is a phosphoric acid solution with a volume concentration of 0.1%; the gradient elution program is as follows:

[0016] From 0 to 10 min, the volume concentration of mobile phase A increased from 5% to 12%, and the volume concentration of mobile phase B decreased from 95% to 88%;

[0017] 10-20min, the volume concentration of mobile phase A increased from 12% to 20%, and the volume concentration of mobile phase B decreased from 88% to 80%;

[0018] 20-30min, the volume concentration of mobile phase A increased from 20% to 22%, and the volume concentration of mobile phase B decreased from 80% to 78%;

[0019] 30-35min, the volume concentration of mobile phase A increased from 22% to 25%, and the volume concentration of mobile phase B decreased from 78% to 75%;

[0020] 35-60min, the volume concentration of mobile phase A increased from 25% to 55%, and the volume concentration of mobile phase B decreased from 75% to 45%;

[0021] At 60-65 min, the volume concentration of mobile phase A decreased from 55% to 5%, and the volume concentration of mobile phase B increased from 45% to 95%.

[0022] Preferably, in the chromatographic conditions, the chromatographic column specifications are: Agilent Eclipse Plus C18, 250mm×4.6mm, 5μm; flow rate: 1mL / min; column temperature: 25°C; detection wavelength: 240nm; injection volume: 5μL.

[0023] Preferably, in the chromatographic conditions, the theoretical plate number calculated based on the rosmarinic acid peak is not less than 20,000.

[0024] Preferably, the test solution is prepared as follows: accurately pipette 10 ml of Chuanbei Zhisou mixture, place it in a 20 ml volumetric flask, add methanol to the scale line, shake well, filter, and obtain the filtrate.

[0025] Preferably, the control fingerprint of Chuanbei Zhisou mixture includes 16 common peaks, peaks 7, 8, 14, 15 and 16 are characteristic peaks of Licorice, and peak 10 is the characteristic peak of Aster.

[0026] Preferably, peak 13 is rosmarinic acid, which is used as a reference peak, peak 2 is p-hydroxybenzoic acid, peak 3 is caffeic acid, and peak 16 is ammonium glycyrrhizinate.

[0027] Preferably, the relative standard deviations RSD of the relative retention times of the 16 common peaks are all less than 3%;

[0028] The similarity was calculated with reference to the control fingerprint of Chuanbei Zhisou Mixture, and the similarity of the fingerprints of Chuanbei Zhisou Mixture was above 0.9.

[0029] The beneficial effects of the present invention include but are not limited to:

[0030] 1. The method for establishing the HPLC fingerprint of Chuanbei Antisough Mixture of the present application is based on the medicinal effects of the components contained in Chuanbei Antisough Mixture, combined with the monarch, minister, adjuvant and guiding ingredients, and taking rosmarinic acid, ammonium glycyrrhizinate, p-hydroxybenzoic acid, caffeic acid and other main components of medicinal materials such as Perilla Leaf, Aster, and Licorice as research indicators, to study the fingerprint of Chuanbei Antisough Mixture, provide a method for establishing and detecting the fingerprint of Chuanbei Antisough Mixture, and provide a reference and basis for the quality control of Chuanbei Antisough Mixture; the method is simple, stable, highly precise and reproducible.

[0031] 2. The fingerprint of Chuanbei Antisough Mixture established according to the method for establishing the HPLC fingerprint of Chuanbei Antisough Mixture of the present application has 16 characteristic peaks that are effectively separated. Therefore, the obtained fingerprint can effectively characterize the quality of Chuanbei Antisough Mixture, which is conducive to comprehensive monitoring of the quality of the drug.

[0032] 3. The method for establishing the HPLC fingerprint of Chuanbei Antisough Mixture of the present application was used to test 10 different batches of Chuanbei Antisough Mixture, and the RSDs of the relative retention times of the chromatographic peaks at the same position were all less than 3%. Therefore, the fingerprint established by this method has good reliability. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] The drawings described herein are used to provide a further understanding of the present invention and constitute a part of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute an improper limitation of the present invention. In the drawings:

[0034] Figure 1The chromatographic peak of the Chuanbei Zhisou mixture test sample under the chromatographic conditions of this application method;

[0035] Figure 2 The chromatographic peak of the reference substance under the chromatographic conditions of the method of this application;

[0036] Figure 3 The chromatographic peak of the reference medicinal material under the chromatographic conditions of the present application method;

[0037] Figure 4 For this application, the mobile phase composition is methanol-water to investigate the spectrum;

[0038] Figure 5 For this application, the mobile phase composition is acetonitrile-water to investigate the spectrum;

[0039] Figure 6 For this application, the mobile phase composition was acetonitrile-0.1% phosphoric acid to investigate the spectrum;

[0040] Figure 7 The fingerprint spectra at different wavelengths are compared and investigated for this application;

[0041] Figure 8 This is the elution gradient investigation profile 1# for this application;

[0042] Fig. 9 This is the elution gradient investigation profile 2# for this application;

[0043] Fig.10 For this application, the elution gradient survey spectrum 3#;

[0044] Fig.11 This is the detection chromatogram of the fingerprint of 10 batches of Chuanbei Zhisou mixture solution for the application;

[0045] Fig.12 This is the reference fingerprint of Chuanbei Zhisou Mixture generated by the average value calculation method in this application. DETAILED DESCRIPTION

[0046] The present invention is further described below in conjunction with specific embodiments, but the protection scope of the present invention is not limited to these embodiments.

[0047] 1. Instruments and reagents:

[0048] 1.1 Instruments

[0049] Agilent 1260 high performance liquid chromatograph; DAD detector; BSA224S-CW electronic analytical balance; HEAL FORCE NW (30K) VF pure water machine;

[0050] 1.2 Reagents

[0051] Reference substances: rosmarinic acid, ammonium glycyrrhizinate, p-hydroxybenzoic acid, caffeic acid;

[0052] Reference medicinal materials: Aster tataricus, Perilla frutescens leaves, Fritillaria cirrhosa, Platycodon grandiflorum, Licorice root, and Pinellia ternata, all of which are sourced from Shandong Hongjitang Pharmaceutical Group Co., Ltd. and meet the standards of the Chinese Pharmacopoeia.

[0053] Test sample: The present invention adopts Chuanbei Zhisou mixture as the self-made pilot sample, batch numbers: 240601, 240602, 240603, 240604, 240605, 240606, 240607, 240608, 240609, 240610.

[0054] Methanol and acetonitrile were of chromatographic grade and purchased from Yuexu Technology (Shanghai) Co., Ltd. Water was ultrapure water, and the other reagents were of analytical grade.

[0055] 2. Method for establishing the HPLC fingerprint of Chuanbei Zhisou mixture

[0056] 1) Preparation of reference solution: Accurately weigh rosmarinic acid, ammonium glycyrrhizinate, p-hydroxybenzoic acid, and caffeic acid, place them in 10 mL volumetric flasks, add methanol and ultrasonically dissolve them, cool, fix the volume, shake well, filter, and take the filtrate as the reference solution.

[0057] Among the above five compounds, the content of rosmarinic acid in Chuanbei Zhisou mixture is relatively stable, and the retention time in the spectrum is moderate and the separation is good. Therefore, rosmarinic acid was selected as the reference substance, and the subsequent corresponding rosmarinic acid chromatographic peak was used as the reference peak.

[0058] 2) Preparation of control medicinal material solution: Take 15g of Aster tataricus, 15g of Perilla leaf, 15g of Platycodon grandiflorum, 50g of Licorice root, 20g of Pinellia ternata and 10g of Fritillaria cirrhosa respectively, and prepare them into single medicinal material solutions according to the process specifications. Take 10mL of the single medicinal material solution and place it in a container. Add appropriate amount of methanol, shake well, filter, and take the filtrate as the control medicinal material solution.

[0059] 3) Preparation of test solution:

[0060] Accurately transfer 10 ml of Chuanbei Antisostomy Mixture into a 20 ml volumetric flask, add methanol to the scale line, shake well, filter, and take the filtrate to obtain the test solution.

[0061] 4) Detection: Take 5 μL of reference solution, reference medicinal material solution and test solution and inject them into high performance liquid chromatography. The chromatographic conditions are as follows:

[0062] Chromatographic column specifications: C18 column, 250mm×4.6mm, 5μm;

[0063] Mobile phase: The mobile phase includes mobile phase A and mobile phase B; wherein A is acetonitrile, and mobile phase B is a phosphoric acid solution with a volume concentration of 0.1%;

[0064] Flow rate: 1 mL / min;

[0065] Column temperature: 25°C;

[0066] Detection wavelength: 240nm;

[0067] Injection volume: 5 μL;

[0068] Gradient elution program:

[0069] From 0 to 10 min, the volume concentration of mobile phase A increased from 5% to 12%, and the volume concentration of mobile phase B decreased from 95% to 88%;

[0070] 10-20min, the volume concentration of mobile phase A increased from 12% to 20%, and the volume concentration of mobile phase B decreased from 88% to 80%;

[0071] 20-30min, the volume concentration of mobile phase A increased from 20% to 22%, and the volume concentration of mobile phase B decreased from 80% to 78%;

[0072] 30-35min, the volume concentration of mobile phase A increased from 22% to 25%, and the volume concentration of mobile phase B decreased from 78% to 75%;

[0073] 35-60min, the volume concentration of mobile phase A increased from 25% to 55%, and the volume concentration of mobile phase B decreased from 75% to 45%;

[0074] At 60-65 min, the volume concentration of mobile phase A decreased from 55% to 5%, and the volume concentration of mobile phase B increased from 45% to 95%.

[0075] The results of HPLC determination were as follows Figure 1 , Figure 2 and Figure 3 .

[0076] 3. Establishment of Chromatography

[0077] 3.1 Selection of chromatographic conditions

[0078] 3.1.1 Investigation of mobile phase composition

[0079] The detection wavelength and the sample preparation method are the same as in "Part 2". The fingerprints under different mobile phase components are examined. The mobile phase compositions are methanol-water, acetonitrile-water, and acetonitrile-0.1% phosphoric acid. The chromatogram is recorded for 120 minutes. The results are shown in Figure 4 , Figure 5 , Figure 6 .

[0080] Depend on Figures 4 to 6 It can be seen that when the mobile phase composition is methanol and water, the baseline of the fingerprint spectrum is uneven. When the mobile phase composition is acetonitrile and water, the baseline of the fingerprint spectrum is more stable than that of methanol, but the peak separation is not good. When the mobile phase composition is acetonitrile and 0.1% phosphoric acid, the baseline of the fingerprint spectrum is stable and the peak separation is better. Therefore, the mobile phase composition of acetonitrile-0.1% phosphoric acid is selected.

[0081] 3.1.2 Selection of detection wavelength

[0082] Except for the detection wavelength conditions, the other basic steps are the same as those for chromatographic detection of the test sample. The wavelength range of the diode array detector is 190-400nm. By comparing the chromatograms of samples at different wavelengths, it can be seen that when the wavelength is greater than 300nm or less than 210nm, the response value of the glycyrrhizic acid chromatographic peak is small. When the wavelength is 260nm, the response value of the auxiliary material potassium sorbate chromatographic peak is too high. Finally, based on the number of chromatographic peaks, chromatographic peak response values, and whether the baseline is stable, 240nm was selected as the detection wavelength of the fingerprint spectrum of Chuanbei Antisweating Mixture. Results are shown in Figure 7 .

[0083] 3.1.3 Elution gradient investigation

[0084] Except for the elution gradient conditions, the other chromatographic conditions and test solution preparation were the same as in "Two", and the gradient elution conditions were carried out according to Table 1, Table 2, and Table 3, respectively.

[0085] Table 1 Solvent elution procedure 1#

[0086]

[0087] Table 2 Solvent elution procedure 2#

[0088]

[0089] Table 3 Solvent elution procedure 3#

[0090]

[0091]

[0092] Accurately pipette 5 μL of the test solution, inject it into the HPLC, and record the chromatogram. Figure 8-Figure 10 According to the test results, it can be seen that when the elution procedure is 2#, rosmarinic acid and adjacent peaks are not separated. When the elution procedure is 3#, the baseline of the fingerprint is not flat, and most peaks are not separated, so the elution procedure 1# is selected as the fingerprint elution condition.

[0093] 4. Optimization of test solution preparation conditions

[0094] 4.1 Selection of extraction solvent

[0095] Accurately pipette 5ml, 10ml, and 15ml of Chuanbei Zhisou Mixture into a 20ml volumetric flask, add methanol to the mark, shake well, filter, and take the filtrate to obtain the test solution. Accurately pipette 5μL of each of the three test solutions, inject into the high performance liquid chromatograph, record the chromatogram for 65min (omitted), and use the number of chromatographic peaks and peak area as evaluation indicators. The test results show that there is no obvious difference in the number of chromatographic peaks of each extraction solvent. When 50% methanol is extracted, the peak area is moderate, and 50% methanol is finally determined as the extraction solvent.

[0096] 4.2 Selection of extraction time

[0097] Accurately transfer 10 ml of Chuanbei cough-relieving mixture into a 20 ml volumetric flask, add an appropriate amount of methanol, and observe ultrasonic extraction (300 W, 40 KHz) for 0 min, ultrasonic extraction (300 W, 40 KHz) for 15 min, and ultrasonic extraction (300 W, 40 KHz) for 30 min. Cool, filter, and take the filtrate as the test solution.

[0098] Accurately pipette 5 μL of each of the three ultrasonically extracted test solutions and inject them into a high performance liquid chromatograph. Record the chromatogram for 65 min and analyze it with the number of chromatographic peaks and peak area as evaluation indicators. The test results show that different ultrasonic times have no significant effect on the number of peaks and peak areas, and the final extraction time is determined to be 0 min.

[0099] Based on the above test results, the preparation method of the test solution of the fingerprint spectrum of Chuanbei Antisough Mixture is determined as follows: accurately transfer 10 ml of Chuanbei Antisough Mixture, place it in a 20 ml volumetric flask, add methanol to the scale line, shake well, filter, and take the filtrate to obtain the test solution.

[0100] 5. Methodological Validation of Fingerprint Establishment Method

[0101] 5.1 Precision experiment

[0102] The precision experiment of the fingerprint establishment method of Chuanbei Zhisou mixture provided by the present invention is carried out, and the process is as follows:

[0103] Preparation of the test solution: accurately pipette 10 ml of Chuanbei Zhisou mixture into a 20 ml volumetric flask, add methanol to the mark, shake well, filter, and take the filtrate to obtain the test solution. Inject the test solution 6 times in parallel, calculate the relative retention time and relative peak area of ​​the main chromatographic peak (accounting for more than 1% of the total peak area), and the results are shown in Tables 4 and 5.

[0104] Table 4 Precision investigation results (relative retention time)

[0105]

[0106] Table 5 Precision investigation results (relative peak area)

[0107]

[0108] 5.2 Solution stability test

[0109] The solution stability experiment was conducted on the fingerprint establishment method of Chuanbei Zhisou mixture provided by the present invention, and the process was as follows:

[0110] Preparation of the test solution: Accurately transfer 10 ml of Chuanbei Zhisou mixture into a 20 ml volumetric flask, add methanol to the scale, shake well, filter, and take the filtrate to obtain the test solution.

[0111] The test solution was injected at 0h, 2h, 4h, 8h, 12h and 24h, and the fingerprint chromatograms were recorded. A total of 6 time points were measured, and the relative retention time and relative peak area of ​​the main chromatographic peaks (accounting for more than 1% of the total peak area) were calculated. The results are shown in Tables 6 and 7. The results show that the test solution has good stability within 24 hours at room temperature.

[0112] Table 6 Stability investigation results (relative retention time)

[0113]

[0114] Table 7 Stability investigation results (relative peak area)

[0115]

[0116]

[0117] 5.3 Repeatability test

[0118] The fingerprint spectrum establishment method of Chuanbei Zhisou mixture provided by the present invention was tested for repeatability, and the process was as follows:

[0119] Preparation of the test solution: Accurately transfer 10 ml of Chuanbei Zhisou mixture into a 20 ml volumetric flask, add methanol to the scale line, shake well, filter, and take the filtrate to obtain the test solution.

[0120] Prepare 6 portions of the test solution in the same manner.

[0121] Accurately pipette the test solution, inject it into the high performance liquid chromatograph, perform gradient elution according to the chromatographic conditions provided, and record the chromatogram. Calculate the relative retention time (see Table 8) and relative peak area (see Table 9) of the main chromatographic peaks (accounting for more than 1% of the total peak area).

[0122] Table 8 Repeatability test results (relative retention time)

[0123]

[0124] Table 9 Repeatability test results (relative peak area)

[0125]

[0126] It can be seen from Tables 8 and 9 that the RSD of the relative retention time and the RSD of the relative peak area are both less than 3%, indicating that the method has good repeatability.

[0127] 6. Establishment of fingerprint

[0128] 6.1 Detection of fingerprint of Chuanbei Zhisou mixture

[0129] Take Chuanbei cough-relieving mixture with batch numbers: 240601, 240602, 240603, 240604, 240605, 240606, 240607, 240608, 240609, and 240610.

[0130] Preparation of multiple batches of test solution: accurately pipette 10 ml of the above 10 batches of Chuanbei Zhisou mixture respectively, place it in a 20 ml volumetric flask, add methanol to the scale line, shake well, filter, and take the filtrate to obtain the test solution; 240601, 240602, 240603, 240604, 240605, 240606, 240607, 240608, 240609, 240610.

[0131] Accurately pipette each batch of test solution, inject it into the HPLC, perform gradient elution according to the provided chromatographic conditions, and record the chromatogram; the results of one batch of test solution refer to Figure 1 . Calculate the relative retention time of the main chromatographic peaks (accounting for more than 1% of the total peak area) (see Table 10).

[0132] Table 10 Fingerprint determination results of 10 batches of Chuanbei Zhisou mixture (relative retention time)

[0133]

[0134] 6.2. Determination of common peaks and acquisition of reference fingerprints

[0135] The AIA format of the fingerprints of 10 batches of Chuanbei Zhisou mixture was exported from the instrument and imported into the Chinese medicine chromatographic fingerprint similarity evaluation system, see the attached Fig.11 , select the chromatographic peaks present in the fingerprints of 10 batches of Chuanbei Zhisou Mixture as the common peak. Generate the control fingerprint of Chuanbei Zhisou Mixture by the average value calculation method, see the attached Fig.12 , calculate the similarity of each common peak, and the results are shown in Table 11.

[0136] Table 11 Similarity results of fingerprints of 10 batches of Chuanbei Zhisou mixture

[0137]

[0138] The above test results show that when the similarity is calculated using the control fingerprint as a reference, the similarities of the fingerprints of the 10 batches of Chuanbei Antisour Mixture are all above 0.99. Therefore, the fingerprint standard of Chuanbei Antisour Mixture is tentatively set as follows: the test sample spectrum should be consistent with the control fingerprint spectrum, and according to the similarity evaluation system of traditional Chinese medicine chromatographic fingerprint spectrum, the similarity between the test sample fingerprint spectrum and the control fingerprint spectrum shall not be less than 0.90 after similarity calculation.

[0139] The above is only the embodiment of the present application, and the protection scope of the present application is not limited by these specific embodiments, but is determined by the claims of the present application. For those skilled in the art, the present application can have various changes and variations. Any modification, equivalent replacement, improvement, etc. made within the technical ideas and principles of the present application should be included in the protection scope of the present application.

Claims

1. A method for establishing a high performance liquid chromatography fingerprint of Chuanbei Zhisou mixture, characterized in that: The following steps are involved: (1) Preparation of test solution: Place a certain volume of Chuanbei Zhisou mixture in a container, add an appropriate amount of methanol to dilute and shake well, filter, and take the filtrate as the test solution; (2) Preparation of reference solution: Take a certain weight of rosmarinic acid, ammonium glycyrrhizinate, p-hydroxybenzoic acid and caffeic acid, place them in volumetric flasks respectively, add appropriate amount of methanol and perform ultrasonic treatment, cool, shake well, and filter to obtain a reference solution; wherein rosmarinic acid is used as a reference; (3) Preparation of control medicinal material solution: Take a certain weight of Aster tataricus, Perilla leaf, Platycodon grandiflorum, Licorice root, Pinellia ternata and Fritillaria cirrhosa respectively, prepare single medicinal material solutions according to the process specifications, take a certain volume of the single medicinal material solution and put it in a container, add an appropriate amount of methanol and shake well, filter, and take the filtrate as the control medicinal material solution; (4) High performance liquid chromatography determination: Taking appropriate amounts of the test solution, the reference solution and the reference medicinal material solution respectively, injecting them into a high performance liquid chromatograph, and recording the chromatograms; analyzing the high performance liquid chromatograms of multiple batches of the test solution to obtain the reference fingerprint of Chuanbei Zhisou Mixture, and calculating the relative retention time of each common peak; The chromatographic conditions of the high performance liquid chromatograph are: The mobile phase includes mobile phase A and mobile phase B, mobile phase A is acetonitrile, and mobile phase B is a phosphoric acid solution with a volume concentration of 0.1%; the gradient elution program is as follows: From 0 to 10 min, the volume concentration of mobile phase A increased from 5% to 12%, and the volume concentration of mobile phase B decreased from 95% to 88%; 10-20min, the volume concentration of mobile phase A increased from 12% to 20%, and the volume concentration of mobile phase B decreased from 88% to 80%; 20-30min, the volume concentration of mobile phase A increased from 20% to 22%, and the volume concentration of mobile phase B decreased from 80% to 78%; 30-35min, the volume concentration of mobile phase A increased from 22% to 25%, and the volume concentration of mobile phase B decreased from 78% to 75%; 35-60min, the volume concentration of mobile phase A increased from 25% to 55%, and the volume concentration of mobile phase B decreased from 75% to 45%; At 60-65 min, the volume concentration of mobile phase A decreased from 55% to 5%, and the volume concentration of mobile phase B increased from 45% to 95%.

2. The method for establishing the HPLC fingerprint of Chuanbei Zhisou mixture according to claim 1, characterized in that: The chromatographic conditions were as follows: column specification: Agilent Eclipse Plus C18, 250 mm × 4.6 mm, 5 μm; flow rate: 1 mL / min; column temperature: 25 °C; detection wavelength: 240 nm; injection volume: 5 μL.

3. The method for establishing the HPLC fingerprint of Chuanbei Zhisou mixture according to claim 1, characterized in that: The preparation of the test solution is as follows: accurately pipette 10 ml of Chuanbei Zhisou mixture, place it in a 20 ml volumetric flask, add methanol to the scale line, shake well, filter, and take the filtrate to obtain the test solution.

4. The method for establishing the HPLC fingerprint of Chuanbei Zhisou mixture according to claim 1, characterized in that: The reference fingerprint of Chuanbei Zhisou mixture includes 16 common peaks, peaks 7, 8, 14, 15 and 16 are characteristic peaks of Licorice, and peak 10 is the characteristic peak of Aster.

5. The method for establishing the HPLC fingerprint of Chuanbei Zhisou mixture according to claim 4, characterized in that: Peak No. 13 is rosmarinic acid, which is used as a reference peak. Peak No. 2 is p-hydroxybenzoic acid, Peak No. 3 is caffeic acid, and Peak No. 16 is ammonium glycyrrhizinate.

6. The method for establishing the HPLC fingerprint of Chuanbei Zhisou mixture according to claim 4 or 5, characterized in that: The relative standard deviations (RSDs) of the relative retention times of the 16 common peaks were all less than 3%; The similarity was calculated with reference to the control fingerprint of Chuanbei Zhisou Mixture, and the similarity of the fingerprints of Chuanbei Zhisou Mixture was above 0.9.

Citation Information

Patent Citations

  • Preparation for treating cough, preparation method and quality control method thereof

    CN105616946A

  • The analytical method for contamination of a Codonopsis lanceolata, Platycodon grandiflorum and Pueraria lobata in the red ginseng and ginseng products

    KR1020170044806A